{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-111522","form_type":"8-K","ticker":"TNON","cik":"0001560293","company_name":"Tenon Medical, Inc.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.738327+00:00","generated_at":"2026-05-16T19:15:08.078951+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tenon Medical closes $2.85M PIPE offering of 2.2M shares and warrants at $1.285/unit","bullets":["Issued 2,217,904 shares and warrants to purchase same number at combined $1.285/unit; warrants exercisable at $1.16 for 3 years.","Gross proceeds of ~$2.85M; net to be used for working capital, product launches, commercial expansion, clinical studies.","Offering included participation from CEO Steven Foster, CCO Nathaniel Grawey, CIO Wyatt Geist, and other accredited investors.","The PIPE closed on November 14, 2025; securities sold under Regulation D exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-111522","json":"https://secwatch.observer/filing/0001213900-25-111522.json","markdown":"https://secwatch.observer/filing/0001213900-25-111522.md","text":"https://secwatch.observer/filing/0001213900-25-111522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1560293/000121390025111522/0001213900-25-111522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1560293/000121390025111522/ea0265746-8k_tenon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:15:08.078951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}